-transparent.png){kind=logo}
Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow. 1989
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
Laboratoire de Pharmacologie Clinique et Moléculaire, Institut Gustave Roussy, Villejuif, France.
Cisplatinum may prove to be a valuable agent for the elimination of diseased cells in the bone marrow of patients with neuroblastoma. In this study, we measured the efficacy of cisplatinum on human neuroblastoma cell lines and on normal human bone marrow progenitors, GM-CFC and CFU-F. Data indicate that the therapeutic index of cisplatinum is high. We set up an experimental model consisting of a mixture of human bone marrow and human neuroblastoma cells in order to confirm these preliminary results in purging conditions. Results indicate that cisplatinum exhibits a high and specific tumoricidal property and appears to be valid in bone marrow purging.
Related Publications
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
September 1996,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
January 1992,
Progress in clinical and biological research,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
November 1985,
Cancer research,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
June 1989,
British journal of cancer,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
August 1990,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
October 1995,
Cancer,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
August 1994,
Cancer,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
October 1988,
European journal of cancer & clinical oncology,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
January 1985,
Progress in clinical and biological research,
L Bettan-Renaud, and
F de Vathaire, and
J Bénard, and
N Morardet, and
N Pauzie, and
S Bayet, and
O Hartmann, and
C Parmentier
July 1986,
Blood,
